arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

BillionToOne, Inc.

BLLN Health Care Medical Specialities
$99.39
Today
as of Sep 4, 16:46 ET
Last 30 days -25.63% Jul 28 → Sep 04
$83.03 $101.01 $118.98 $136.95 $154.93 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$97.84
High
$100.72
Low
$96.14
Volume
$976,440
Avg Vol
$487,260
Mkt Cap
$6.3B
P/E (TTM)
168.46
Beta
—
52w High
$150.44
52w Low
$61.96
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Sep 2 · 20:05 PR PR Newswire
BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
Sep 2 · 10:26 MT Newswires
Canaccord Genuity Initiates BillionToOne at Buy With $120 Price Target
Sep 1 · 14:14 MT Newswires
BillionToOne Launches New Liquid Biopsy Test to Help Identify Tissue of Origin
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$62
$150
42% of range
Avg surprise (last 1)
+3,300%
Avg reaction (last 1)
+1.9%
100% positive
Latest IV / EM
59%
EM ±9.2% · $100 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.47$-1.02$-0.56$-0.11$0.34 Actual $-1.47Actual $-0.39Actual $-0.02Actual $0.10Actual $0.34Est $0.01Actual $0.15 SepMarJunSepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-15M$18M$50M$82M$115M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.15 — — — — financials
Wed May 6, 2026Mar/2026 $0.34 $0.01 +3,300% — +1.9% earnings
Tue Sep 30, 2025Sep 2025 $0.10 — — — — financials
Mon Jun 30, 2025Jun 2025 $-0.02 — — — — financials
Mon Mar 31, 2025Mar 2025 $-0.39 — — — — financials
Mon Sep 30, 2024Sep 2024 $-1.47 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$109M$108M—$84M$67M$59M—$38M
Cost of revenue$32M$29M—$25M$23M$21M—$18M
Gross profit$77M$79M—$58M$43M$38M—$20M
Operating income$6M$18M—$10M$-2M$-2M—$-13M
Net income$8M$18M—$6M$-246,000$-4M—$-15M
EPS (diluted)$0.15$0.34—$0.10$-0.02$-0.39—$-1.47

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$549M$537M$496M$195M——$191M—
Inventory$21M$19M$18M$17M——$9M—
Total current assets$651M$624M$561M$252M——$228M—
Total assets$730M$701M$633M$328M——$302M—
Long-term debt$91M$90M$57M$55M————
Total liabilities$193M$195M$153M$148M——$134M—
Total equity$537M$506M$480M$-240M$-250M$-253M$-252M$-243M

Implied volatility — last 90 days

42%89%135%182%228% Jun 07 — IV 84% · EM ±11.6%Jun 08 — IV 92% · EM ±12.2%Jun 09 — IV 95% · EM ±11.9%Jun 10 — IV 89% · EM ±10.5%Jun 11 — IV 88% · EM ±9.7%Jun 12 — IV 90% · EM ±9.2%Jun 15 — IV 88% · EM ±6.3%Jun 16 — IV 106% · EM ±6.2%Jun 17 — IV 119% · EM ±5.0%Jun 19 — IV 74% · EM ±16.5%Jun 22 — IV 77% · EM ±16.0%Jun 23 — IV 75% · EM ±15.2%Jun 24 — IV 76% · EM ±15.1%Jun 25 — IV 72% · EM ±14.1%Jun 26 — IV 75% · EM ±14.4%Jun 29 — IV 78% · EM ±13.8%Jun 30 — IV 72% · EM ±12.5%Jul 01 — IV 76% · EM ±12.7%Jul 02 — IV 73% · EM ±11.8%Jul 03 — IV 75% · EM ±11.7%Jul 06 — IV 75% · EM ±10.3%Jul 07 — IV 81% · EM ±10.7%Jul 08 — IV 84% · EM ±10.6%Jul 09 — IV 76% · EM ±8.9%Jul 10 — IV 77% · EM ±8.6%Jul 13 — IV 90% · EM ±7.5%Jul 14 — IV 79% · EM ±5.7%Jul 15 — IV 54% · EM ±3.2%Jul 16 — IV 90% · EM ±3.8%Jul 20 — IV 83% · EM ±19.6%Jul 21 — IV 79% · EM ±18.3%Jul 22 — IV 78% · EM ±17.8%Jul 23 — IV 75% · EM ±16.9%Jul 24 — IV 74% · EM ±16.3%Jul 27 — IV 78% · EM ±16.3%Jul 28 — IV 78% · EM ±15.9%Jul 29 — IV 80% · EM ±16.0%Jul 30 — IV 79% · EM ±15.4%Jul 31 — IV 78% · EM ±14.9%Aug 03 — IV 72% · EM ±12.8%Aug 04 — IV 79% · EM ±13.7%Aug 05 — IV 229% · EM ±38.2%Aug 06 — IV 66% · EM ±10.6%Aug 07 — IV 66% · EM ±10.2%Aug 10 — IV 60% · EM ±8.3%Aug 11 — IV 60% · EM ±7.9%Aug 12 — IV 55% · EM ±6.9%Aug 13 — IV 55% · EM ±6.5%Aug 14 — IV 43% · EM ±4.7%Aug 17 — IV 43% · EM ±3.6%Aug 18 — IV 51% · EM ±3.7%Aug 19 — IV 74% · EM ±4.4%Aug 20 — IV 70% · EM ±2.9%Aug 24 — IV 60% · EM ±12.6%Aug 25 — IV 57% · EM ±11.7%Aug 26 — IV 56% · EM ±11.2%Aug 27 — IV 57% · EM ±11.2%Aug 28 — IV 50% · EM ±9.5%Aug 31 — IV 58% · EM ±10.2%Sep 01 — IV 59% · EM ±10.1%Sep 02 — IV 60% · EM ±10.0%Sep 03 — IV 57% · EM ±9.3%Sep 04 — IV 59% · EM ±9.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in